MED - Medifast, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
1.21B
Enterprise Value 3
1.07B
Trailing P/E
17.26
Forward P/E 1
12.00
PEG Ratio (5 yr expected) 1
0.74
Price/Sales (ttm)
1.89
Price/Book (mrq)
9.56
Enterprise Value/Revenue 3
1.68
Enterprise Value/EBITDA 6
11.52

Trading Information

Stock Price History

Beta (3Y Monthly) 0.75
52-Week Change 3-52.00%
S&P500 52-Week Change 38.19%
52 Week High 3219.99
52 Week Low 395.10
50-Day Moving Average 3102.34
200-Day Moving Average 3121.09

Share Statistics

Avg Vol (3 month) 3309.19k
Avg Vol (10 day) 3176.65k
Shares Outstanding 511.84M
Float 10.65M
% Held by Insiders 13.98%
% Held by Institutions 197.80%
Shares Short (Sep 30, 2019) 43.39M
Short Ratio (Sep 30, 2019) 410.68
Short % of Float (Sep 30, 2019) 440.17%
Short % of Shares Outstanding (Sep 30, 2019) 428.62%
Shares Short (prior month Aug 30, 2019) 42.72M

Dividends & Splits

Forward Annual Dividend Rate 43
Forward Annual Dividend Yield 43.04%
Trailing Annual Dividend Rate 32.73
Trailing Annual Dividend Yield 32.74%
5 Year Average Dividend Yield 4N/A
Payout Ratio 446.27%
Dividend Date 3Nov 7, 2019
Ex-Dividend Date 4Jun 27, 2019
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 11.22%
Operating Margin (ttm)14.00%

Management Effectiveness

Return on Assets (ttm)30.27%
Return on Equity (ttm)62.53%

Income Statement

Revenue (ttm)638.06M
Revenue Per Share (ttm)53.77
Quarterly Revenue Growth (yoy)59.50%
Gross Profit (ttm)379.9M
EBITDA 93.24M
Net Income Avi to Common (ttm)71.57M
Diluted EPS (ttm)5.91
Quarterly Earnings Growth (yoy)51.30%

Balance Sheet

Total Cash (mrq)113.52M
Total Cash Per Share (mrq)9.63
Total Debt (mrq)12.98M
Total Debt/Equity (mrq)10.30
Current Ratio (mrq)2.26
Book Value Per Share (mrq)10.67

Cash Flow Statement

Operating Cash Flow (ttm)69.5M
Levered Free Cash Flow (ttm)47.1M